Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
NCT ID: NCT00695357
Last Updated: 2009-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
832 participants
OBSERVATIONAL
2008-04-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study
Exclusion Criteria
* COPD Patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca SA, Greece
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zachariadis Manolis, MD
Role: PRINCIPAL_INVESTIGATOR
Euroclinic, Athens, Greece
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Aleksandroupoli, , Greece
Research Site
Amaliáda, , Greece
Research Site
Argos, , Greece
Research Site
Arta, , Greece
Research Site
Athens, , Greece
Research Site
Chania, , Greece
Research Site
Drama, , Greece
Research Site
Githio, , Greece
Research Site
Goúnari, , Greece
Research Site
Heraklion, , Greece
Research Site
Imathia, , Greece
Research Site
Ioannina, , Greece
Research Site
Kalamata, , Greece
Research Site
Katerini, , Greece
Research Site
Kavala, , Greece
Research Site
Komotini, , Greece
Research Site
Lamia, , Greece
Research Site
Larissa, , Greece
Research Site
Nafpaktos, , Greece
Research Site
Neapoli, , Greece
Research Site
Pátrai, , Greece
Research Site
Pírgos, , Greece
Research Site
Rafina, , Greece
Research Site
Serres, , Greece
Research Site
Sparti, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Trikala, , Greece
Research Site
Tripoli, , Greece
Research Site
Véria, , Greece
Research Site
Volos, , Greece
Research Site
Xalkida, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RGR-DUM-2008/1
Identifier Type: -
Identifier Source: org_study_id